//
Vijay Shyam-Sundar - British Cardiovascular Society (BCS) , 2021
Therapeutic Area
Disease
Drug/Treatment
Infectious Diseases (ID)
Coronavirus disease
N/A
Joel Giblett - Transcatheter Cardiovascular Therapeutics (TCT) , 2018
Therapeutic Area
Disease
Drug/Treatment
Endocrine/metabolic Diseases (ME)
Diabetes
Intranasal glucagon
Kalaivani Mahadevan - Transcatheter Cardiovascular Therapeutics (TCT) , 2019
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Acute Coronary Syndromes
N/A
A Masoodi - European Society of Regional Anaesthesia & Pain Therapy (ESRA) , 2022
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Gastrointestinal bleeding
N/A
E. Hassanin - American Thoracic Society (ATS) , 2022
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
No obstructive coronary artery disease
N/A
I. Kirti - American Thoracic Society (ATS) , 2022
Therapeutic Area
Disease
Drug/Treatment
Autoimmune (AI)
Myocardial infarction
Diphenhydramine
S. Al Qatarneh - American Thoracic Society (ATS) , 2022
Therapeutic Area
Disease
Drug/Treatment
Blood/haematological Diseases
Deep vein thrombosis
Heparin
Bilal Ashraf - American Society of Hematology (ASH) , 2021
Therapeutic Area
Disease
Drug/Treatment
Blood/haematological Diseases
Venous thrombosis
N/A
Ana Carolina Oliver - American Society of Hematology (ASH) , 2021
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Cardiotoxicity
N/A
Abhishek Chakraborty - Pediatric Academic Societies (PAS) , 2022
Therapeutic Area
Disease
Drug/Treatment
Cardiovascular (CVS)
Viral myocarditis
N/A